Clinically available evaluation of bone disease in breast cancer--validity and cost effectiveness
Coleman, R.E.
Canadian Journal of Oncology 5(Suppl 1): 69-79
1995
ISSN/ISBN: 1183-2509 PMID: 8853529 Document Number: 452729
Bone metastases present major clinical challenges to oncologists. They are common, require a variety of palliative treatments and are associated with a decline in quality of life. Diagnosis and assessment currently rely principally on the structural consequences of metastatic bone involvement. In this review, imaging techniques, biochemical markers bone metabolism. Subjective and quality of life assessments and marrow markers are discussed and their place in diagnosis and monitoring of response to treatment considered.
Document emailed within 1 workday
Related Documents
Kawalec, P.ł; Holko, P.ła.; Szkultecka-Debek, M.; Paszulewicz, A.; Boratyńska, M.; Głyda, M.; Ignacak, E.; Maks, J.; Russel-Szymczyk, M.; Kaweczyńska-Lasoń, A. 2013: The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(204): 332-338Kudoh, S.; Kawamura, H.; Suzuki, Y.; Matsuzaki, M.; Nishina, M.; Tsukamoto, M. 1996: Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 787-790
Raab, S.S.; Slagel, D.D.; Hughes, J.H.; Thomas, P.A.; Silverman, J.F. 1997: Sensitivity and cost-effectiveness of fine-needle aspiration with immunocytochemistry in the evaluation of patients with a pulmonary malignancy and a history of cancer Archives of Pathology and Laboratory Medicine 121(7): 695-700
Zissimopoulos, A.; Matthaios, D.; Matthaiou, E.; Mantadakis, E.; Karaitianos, I. 2007: Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(4): 505-511
Polevaia, E.B.; Ivanov, V.M.; Koposova, T.L.; Gabuniia, R.I.; Chinareva, I.V. 1984: Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment Voprosy Onkologii 30(4): 23-29
Thurgar, E.; Barton, S.; Karner, C.; Edwards, S.J. 2016: Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation Health Technology Assessment 20(24): V-Vi 1-486
Norum, J.; Andreassen, T. 2000: Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective? Anticancer Research 20(3b): 2193-2196
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Cheng, C.; Komljenovic, D.; Pan, L.; Dimitrakopoulou-Strauss, A.; Strauss, L.; Bäuerle, T. 2011: Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG Hellenic Journal of Nuclear Medicine 14(1): 15-20
Luckett, T.; Phillips, J.; Agar, M.; Lam, L.; Davidson, P.M.; McCaffrey, N.; Boyle, F.; Shaw, T.; Currow, D.C.; Read, A.; Hosie, A.; Lovell, M. 2018: Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial Bmc Health Services Research 18(1): 558
Inoue, T.; Inoue, T. 1998: Clinical evaluation based on cost-effectiveness Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(1): 13-19
Sendi, P.P.; Bucher, H.C.; Steurer, J. 1998: Critical evaluation of a cost-effectiveness analysis Praxis 87(49): 1695-1702
Taguchi, T. 2011: Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer Clinical Calcium 21(3): 429-438
Ogawa, H.; Tominaga, S.; Yoshida, M.; Kubo, K.; Takeuchi, S.; Wada, M. 1989: Effectiveness, accuracy, and acceptability of breast self-examination as a breast cancer screening method Gan no Rinsho. Japan Journal of Cancer Clinics 35(2): 195-201
Shade, S.B.; Kevany, S.; Onono, M.; Ochieng, G.; Steinfeld, R.L.; Grossman, D.; Newmann, S.J.; Blat, C.; Bukusi, E.A.; Cohen, C.R. 2013: Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV services Aids 27(Suppl 1): S87-S92
David, Y.J.; Tahir, A.; Riaz, M. 2017: Cost effectiveness evaluation of hepatitis C therapy in Lahore Pakistan Journal of Pharmaceutical Sciences 30(6): 2233-2237
Philips, Z.; Barraza-Llorens, M.; Posnett, J. 2000: Evaluation of the relative cost-effectiveness of treatments for infertility in the UK Human Reproduction 15(1): 95-106